Charles Schwab Investment Management Inc Gilead Sciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 7,528,015 shares of GILD stock, worth $629 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,528,015
Previous 7,367,260
2.18%
Holding current value
$629 Million
Previous $540 Million
4.29%
% of portfolio
0.1%
Previous 0.13%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.64 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.38 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.05 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.96 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $105B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...